Search

Pulse Biosciences Inc

Closed

SectorHealthcare

53.21 -1.17

Overview

Share price change

24h

Current

Min

52.22

Max

53.84

Key metrics

By Trading Economics

Income

-6.1M

-25M

Sales

33K

434K

EPS

-0.36

Profit margin

-5,681.336

Employees

116

EBITDA

-5.8M

-25M

Dividends

By Acuity

Next Earnings

4 Nov 2026

Market Stats

By TradingEconomics

Market Cap

1.2B

3.8B

Previous open

54.38

Previous close

53.21

News Sentiment

By Acuity

13%

87%

10 / 339 Healthcare

Pulse Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

11 Sept 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10 Sept 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9 Sept 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

8 Sept 2026, 23:31 UTC

Pulse Biosciences Inc shares are higher in after-market trading, recovering significantly and nearing the upper end of their one-month range.

4 Sept 2026, 22:26 UTC

Pulse Biosciences Inc. shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

3 Sept 2026, 22:21 UTC

Pulse Biosciences Inc shares are lower in after-market hours amid notable volatility, reversing gains from the previous four sessions without specific news to explain the decline.

2 Sept 2026, 23:41 UTC

Pulse Biosciences Inc shares are higher in after-market hours, recovering from earlier losses amid broader market strength following weaker job growth data from ADP.

1 Sept 2026, 22:51 UTC

Pulse Biosciences Inc shares are higher in after-market trading, following earlier volatility amid macroeconomic pressures and a mixed sentiment in the health care equipment sector.

31 Aug 2026, 20:07 UTC

Pulse Biosciences is trading higher, reflecting broader market gains since Friday. The stock remains above its 20-day moving average and near its one-month range.

29 Aug 2026, 00:01 UTC

Pulse Biosciences Inc shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the top of its one-month range.

28 Aug 2026, 23:46 UTC

Pulse Biosciences Inc is trading lower in after-market hours, with no specific news identified to explain the movement. Broader market conditions may be influencing sentiment.

27 Aug 2026, 20:07 UTC

News

Pulse Biosciences Inc. is higher today, recovering from a prior session decline. Analyst Mike Matson has a Buy rating and $58 price target.

26 Aug 2026, 23:21 UTC

Pulse Biosciences Inc is higher in after-market trading, reflecting a broader market trend. The price remains near the upper end of its one-month range.

25 Aug 2026, 20:07 UTC

Shares of Pulse Biosciences Inc. are lower today, reflecting routine volatility amid a broader market backdrop of declining oil prices and Treasury yields.

24 Aug 2026, 23:36 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a brief peak, amid broader market concerns over geopolitical tensions affecting oil supply.

20 Aug 2026, 20:06 UTC

Pulse Biosciences Inc is higher in Thursday's session, reflecting a broader market trend. The stock is trading above its 20-day moving average.

19 Aug 2026, 19:16 UTC

Pulse Biosciences Inc is trading higher, maintaining gains since Tuesday's close. The stock remains above its 20-day moving average and near its one-month range high.

18 Aug 2026, 19:56 UTC

News

Pulse Biosciences announced inducement grants for new employees, raising potential dilution concerns. Shares are trading lower during Tuesday's session, retracing from an early peak.

17 Aug 2026, 22:36 UTC

Pulse Biosciences Inc shares are trading higher in after-market hours. The stock has gained significantly over the past month, reflecting broader market dynamics.

14 Aug 2026, 19:11 UTC

Pulse Biosciences Inc shares are declining, breaking a trend of higher closes. The broader market reacts to an unexpected decline in U.S. retail sales.

13 Aug 2026, 20:06 UTC

Pulse Biosciences Inc shares are higher, maintaining gains since Wednesday's close despite earlier intraday volatility and no specific news driving the movement.

12 Aug 2026, 20:06 UTC

Pulse Biosciences Inc. shares are lower today, continuing a decline after an early peak. The asset remains above its 20-day moving average.

11 Aug 2026, 23:01 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reversing earlier gains despite being above its 20-day moving average. No specific news was identified.

10 Aug 2026, 21:01 UTC

Pulse Biosciences Inc shares are lower in after-market hours, reflecting no specific news to explain the movement. The asset remains above its 20-day moving average.

7 Aug 2026, 19:51 UTC

News

Pulse Biosciences shares are higher after reporting second-quarter revenue of $434,000 and increasing patient enrollment targets for its pivotal trial.

6 Aug 2026, 22:16 UTC

News

Pulse Biosciences reported a net loss of $24.7 million for Q2 2026. Shares are trading higher after announcing significant progress in its cardiac catheter program.

5 Aug 2026, 20:06 UTC

Pulse Biosciences Inc shares are lower during Wednesday's trading session, reversing from a recent trend of higher daily closes. No specific news was identified.

3 Aug 2026, 20:03 UTC

Pulse Biosciences Inc shares are higher today, driven by a significant advance in the Health Care Equipment sector and unusually high trading volume.

31 Jul 2026, 19:16 UTC

Pulse Biosciences Inc is gaining during Friday's session, reaching a high above Thursday's close. The stock remains above its 20-day moving average.

30 Jul 2026, 20:09 UTC

Event

Pulse Biosciences' NANOPULSE-AF Study enrollment surpasses midpoint, supporting stock gains since Wednesday. Shares remain above the 20-day moving average amid market volatility.

Peer Comparison

Price change

Pulse Biosciences Inc Forecast

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Sentiment

By Acuity

10 / 339 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat